HealthcareServices

Proliferative Diabetic Retinopathy (PDR) Market Outlook 2026–2030: Key Business Drivers and Trends

March 2, 2026March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the proliferative diabetic retinopathy (pdr) market from 2026–2035 with trusted insights from The Business Research Company

How much is the Proliferative Diabetic Retinopathy (PDR) Market valued at in 2026, and what valuation is forecast for 2030?

The market size for proliferative diabetic retinopathy (pdr) has observed swift expansion in recent years. This market is projected to increase from $2.69 billion in 2025 to $2.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.3%. In the past, this growth was primarily a result of the rising prevalence of diabetes mellitus, the broader application of retinal laser therapies, the development of more ophthalmology clinics, better access to eye care services, and an increase in diabetic screening programs.

The market size for proliferative diabetic retinopathy (PDR) is projected to experience substantial expansion in the coming years. This market is predicted to reach $4.49 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.0%. This anticipated growth during the forecast period stems from several factors, including the escalating demand for long-acting injectable therapies, the rising integration of AI-based retinal diagnostics, the broader availability of outpatient ophthalmic procedures, a heightened emphasis on vision preservation strategies, and increased investment in the management of diabetic eye disease. Key trends anticipated during this period encompass the growing acceptance of anti-VEGF therapies, the increasing application of advanced retinal imaging technologies, a greater emphasis on early screening and diagnosis, the expansion of minimally invasive surgical interventions, and improved integration of multidisciplinary diabetes care.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12911&type=smp

What Drivers Are Influencing The Growth Of The Proliferative Diabetic Retinopathy (PDR) Market?

The increasing incidence of diabetes is projected to drive expansion within the proliferative diabetic retinopathy (PDR) market in the future. Diabetes is a long-term health condition defined by abnormally high blood glucose (sugar) levels. It serves as the primary etiology for proliferative diabetic retinopathy, a condition manageable through diverse treatments aimed at preventing additional retinal harm and sustaining eyesight. For example, data from June 2024, released by the National Health Service (NHS), a UK government department, indicated a rise in affected individuals under 40, from 173,166 in 2022 to 216,440 in 2023. This substantial increase underscores a worrying pattern within this demographic, as the statistics demonstrate a swift rise in diabetes cases among younger populations. Consequently, the growing occurrence of diabetes fuels the proliferative diabetic retinopathy (PDR) market.

What Segments Are Included Within The Proliferative Diabetic Retinopathy (PDR) Market?

The proliferative diabetic retinopathy (pdr) market covered in this report is segmented –

1) By Treatment Type: Anti-VEGF (Vascular Endothelial Growth Factor) Therapy, Intraocular Steroids, Laser Surgery, Vitrectomy

2) By Mode of Administration: Injectables, Intravitreal Administration Focus, Other Mode Of Administrations

3) By Application: Hospitals, Clinics, Other Applications

Subsegments:

1) By Anti-VEGF Therapy: Aflibercept, Ranibizumab, Bevacizumab

2) By Intraocular Steroids: Triamcinolone Acetonide, Dexamethasone Implant, Fluocinolone Acetonide

3) By Laser Surgery: Focal Laser Photocoagulation, Panretinal Laser Photocoagulation

4) By Vitrectomy: Pars Plana Vitrectomy, Anterior Vitrectomy

What Trends Are Driving The Growth Trajectory Of The Proliferative Diabetic Retinopathy (PDR) Market?

Major companies operating in the proliferative diabetic retinopathy (PDR) market are concentrating on developing advanced solutions, including AI-driven autonomous retinal screening systems and portable fundus cameras, to enhance early detection and improve patient outcomes. AI-based autonomous screening systems are engineered to analyze retinal images independently, providing rapid and accurate identification of diabetic retinopathy, while handheld fundus cameras enable convenient and accessible retinal imaging. For instance, in April 2024, Optomed Plc, a Finland-based medical technology company, secured U.S. Food and Drug Administration (FDA) clearance for its Optomed Aurora with AEYE, a handheld AI fundus camera capable of autonomously detecting referable diabetic retinopathy, thereby extending the accessibility and efficiency of PDR screening beyond traditional clinical settings.

Who Are The Major Companies Operating In The Proliferative Diabetic Retinopathy (PDR) Market?

Major companies operating in the proliferative diabetic retinopathy (pdr) market are Johnson And Johnson Limited, F Hoffmann La Roche Ltd, AbbVie Inc, Bayer AG, Novartis AG, Merck KGaA, Kubota Vision Inc, Teva Pharmaceutical Industries Ltd, Regeneron Pharmaceuticals Inc, Mylan NV, Santen Pharmaceutical Co Ltd, Lupin Limited, Genentech Inc, Alcon Inc, Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co Ltd, Bausch And Lomb Corporation, Heidelberg Engineering GmbH, Iridex Corporation, Lumenis Ltd, Optos plc, Zeiss Meditec India Pvt Ltd, Alimera Sciences Inc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/proliferative-diabetic-retinopathy-pdr-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Proliferative Diabetic Retinopathy (PDR) Market?

North America was the largest region in the proliferative diabetic retinopathy market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the proliferative diabetic retinopathy (pdr) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Proliferative Diabetic Retinopathy (PDR) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12911&type=smp

Browse Through More Reports Similar to the Global Proliferative Diabetic Retinopathy (PDR) Market 2026, By The Business Research Company

Diabetic Neuropathy Market Report 2026

https://www.thebusinessresearchcompany.com/report/diabetic-neuropathy-global-market-report

Non Proliferative Diabetic Retinopathy Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-proliferative-diabetic-retinopathy-global-market-report

Diabetic Retinopathy Market Report 2026

https://www.thebusinessresearchcompany.com/report/diabetic-retinopathy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795